Document Detail


Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis.
MedLine Citation:
PMID:  21105108     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Systemic activation of the inflammatory immune system contributes to the progression of cirrhosis with ascites. Immune cells become activated after interacting at the mesenteric lymph nodes (MLNs) with bacteria translocated from the gut, and thereafter reach the bloodstream through recirculation. It is unknown whether systemic activation of the immune system is present in pre-ascitic cirrhosis, in which gut bacterial translocation has not been described. The purpose of this study was to determine whether systemic activation of the immune system initiates in rats with compensated carbon tetrachloride (CCl(4))-induced cirrhosis, and if so to establish the activation site of immune cells. We studied the activation status of immune cells in peripheral blood, MLNs, and hepatic lymph nodes (HLNs). Systemic inflammation was present in rats with cirrhosis, as shown by expansion (P < 0.01) of circulating total and inflammatory monocytes and recently activated CD134(+) T helper (T(h)) cells. The same populations of cells were increased (P < 0.01) in MLNs and HLNs. Bacterial translocation was absent in rats with cirrhosis or control rats, but bacterial DNA fragments were present in the MLNs of 54% of rats with cirrhosis. The liver was the source of activated immune cells present in the blood, as shown by the direct correlation between activated T(h) cells in the blood and HLNs, but not in MLNs, and the normalization by gut decontamination with antibiotics of activated cells in MLNs, but not in the blood or HLNs. Conclusion: In experimental cirrhosis, systemic activation of the immune system occurs before ascites development and is driven by recirculation of cells activated in HLNs. In addition, in compensated cirrhosis, bacterial DNA fragments reach the MLNs, where they elicit a local inflammatory response.
Authors:
María Úbeda; Leticia Muñoz; María-José Borrero; David Díaz; Rubén Francés; Jorge Monserrat; Margaret Lario; Lourdes Lledó; José Such; Melchor Álvarez-Mon; Agustín Albillos
Related Documents :
16423888 - Overexpression of bcl-2 by activated human hepatic stellate cells: resistance to apopto...
19398228 - Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects...
11347718 - Apoptosis in diseases of the liver.
10900228 - Hepatic and central nervous system cytochrome p450 are down-regulated during lipopolysa...
22571318 - Multi-walled carbon nanotubes induce cox-2 and inos expression via map kinase-dependent...
19780708 - Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Hepatology (Baltimore, Md.)     Volume:  52     ISSN:  1527-3350     ISO Abbreviation:  Hepatology     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-24     Completed Date:  2011-01-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8302946     Medline TA:  Hepatology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2086-95     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 American Association for the Study of Liver Diseases.
Affiliation:
Laboratory of Immune System Disease, Department of Medicine, University of Alcalá, Alcalá de Henares, Madrid Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Carbon Tetrachloride Poisoning / immunology*
DNA, Bacterial / metabolism
Inflammation
Liver / physiopathology*
Liver Cirrhosis, Experimental / immunology*
Rats
Chemical
Reg. No./Substance:
0/DNA, Bacterial

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genetic variations at loci involved in the immune response are risk factors for hepatocellular carci...
Next Document:  Therapeutic trials in nonalcoholic steatohepatitis: insulin sensitizers and related methodological i...